Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 57
Page 57 of 114 · 1029 articles
Implied Certification After Escobar
How the Supreme Court's Escobar decision held that implied certification can support liability at least where two conditions are s…
Healthcare Fraud Sentencing: How Loss Is Calculated
How federal courts calculate actual versus intended loss under Section 2B1.1, and why the billed-amount presumption is often the k…
UPIC Interview Requests: Should You Agree
A voluntary UPIC interview request is not a subpoena, but an unprepared answer can still shape a later civil or criminal fraud ref…
UPIC-Initiated Medicare Payment Suspensions
How a UPIC suspends Medicare payments on a credible allegation of fraud, the 15-day rebuttal window, and how long a suspension can…
Signature Log Deficiencies: The Most Common Audit Finding
A missing or illegible signature is one of the most common PBM audit findings pharmacies face, and one of the most recoverable wit…
Grand Jury Testimony: Preparing a Provider Witness
How DOJ classifies grand jury witnesses as target, subject, or witness, and what a physician should know before testifying.
Self-Auditing Your Pharmacy Before the PBM Does
How pharmacies can sample their own claims, fix the systemic cause behind errors, and document the fix before a PBM audit finds it…
Mobile Wound Care Practices Under Federal Review
Travel-based wound care models are drawing federal scrutiny over place-of-service coding, patient selection, and visit documentati…
Going to Trial in a False Claims Act Case
How FCA trial rates, jury standards, and treble-damages exposure shape the decision to settle or fight a False Claims Act case.